Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week open-label fesoterodine study in women with overactive bladder and sexual function outcomes
2010-023851-27Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fesoterodine in overactive bladder (OAB), sponsored by King's College Hospital. Primary endpoints: Change in PISQ-12 score at week 12 and Change in SQOL score at week 12. Started Apr 2012; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2010-023851-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023851-27.